Unibrom Eye Drops

Product Overview

Unibrom Eye Drops is a bromfenac-based ophthalmic solution classified as a nonsteroidal anti-inflammatory drug (NSAID). This prescription medication is specifically formulated to manage postoperative ocular inflammation and pain following cataract extraction surgery.

Therapeutic Indications

Unibrom Eye Drops are clinically indicated for the treatment of postoperative inflammation and the prophylaxis of ocular pain in patients who have undergone cataract surgery. The formulation aids in reducing surgical trauma-induced inflammation while enhancing patient comfort during the recovery period.

Administration Guidelines

For proper instillation of Unibrom Eye Drops, first perform thorough hand hygiene. With the head tilted backward, gently retract the lower eyelid to form a conjunctival sac. Position the dropper above the eye without corneal contact and administer the prescribed number of drops. Maintain gentle eyelid closure for 1-2 minutes post-instillation to optimize drug absorption.

Mechanism of Action

The active pharmaceutical ingredient, bromfenac, exerts its therapeutic effect through selective inhibition of cyclooxygenase-2 (COX-2) enzyme activity. This pharmacological action suppresses prostaglandin synthesis, thereby attenuating the inflammatory cascade and associated pain mediators in ocular tissues.

Dosage Regimen

The standard therapeutic protocol for Unibrom Eye Drops involves unilateral or bilateral administration of one drop daily. Treatment should commence 24 hours preoperatively and continue for 14 days postoperatively, unless otherwise directed by an ophthalmologist. Strict adherence to prescribed dosing frequency is essential to maintain therapeutic efficacy.

Therapeutic Advantages

• Effective suppression of postoperative ocular inflammation
• Significant reduction in postsurgical pain perception
• Enhanced wound healing through inflammation control
• Improved patient comfort during recovery

Adverse Reactions

The most frequently reported ocular adverse effects include transient instillation site reactions (burning/stinging), blurred vision, photophobia, and conjunctival hyperemia. Systemic absorption may rarely cause headache or dysgeusia. Persistent or severe reactions warrant immediate ophthalmologic consultation.

Important Precautions

• Contraindicated in patients with hypersensitivity to NSAIDs or formulation excipients
• Exercise caution in patients with bleeding diatheses or those taking anticoagulants
• Maintain strict aseptic technique during administration
• Discontinue immediately if corneal epithelial breakdown occurs
• May delay corneal wound healing in some patients

Storage Conditions

Maintain product integrity by storing Unibrom Eye Drops at controlled room temperature (15-30°C). Protect from light exposure and excessive humidity. Ensure proper container closure after each use. Discard 28 days after initial opening.

Medical Disclaimer

The provided information represents current pharmacological data that has undergone medical review. This content serves educational purposes only and should not supersede professional medical advice, diagnosis, or treatment. Complete drug information including contraindications, interactions, and special warnings may not be fully detailed herein. Always consult your ophthalmologist regarding any medical concerns or before initiating/changing any treatment regimen. This information aims to facilitate informed patient-physician discussions, not replace clinical judgment.